Glenmede Trust’s NRC Health Common Stock NRC Stock Holding History

Glenmede Trust’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,175	Closed	-$284K	–	1399
2024 Q1	$284K	Buy	7,175 +542	+8%	+$21.4K	﹤0.01%	1072
2023 Q4	$262K	Buy	6,633 +746	+13%	+$31.2K	﹤0.01%	1069
2023 Q3	$261K	Sell	5,887 -207	-3%	-$9.03K	﹤0.01%	1039
2023 Q2	$265K	Hold	6,094	–	–	﹤0.01%	1014
2023 Q1	$265K	Sell	6,094 -369	-6%	-$16.3K	﹤0.01%	1019
2022 Q4	$241K	Buy	6,463 +1,203	+23%	+$46.5K	﹤0.01%	1042
2022 Q3	$209K	Sell	5,260 -635	-11%	-$23.5K	﹤0.01%	1078
2022 Q2	$225K	Sell	5,895 -754	-11%	-$27.3K	﹤0.01%	1074
2022 Q1	$263K	Buy	6,649 +1,007	+18%	+$39.4K	﹤0.01%	1067
2021 Q4	$234K	Buy	5,642 +319	+6%	+$13.9K	﹤0.01%	1109
2021 Q3	$224K	Sell	5,323 -289	-5%	-$14.6K	﹤0.01%	1107
2021 Q2	$257K	Buy	+5,612	New	+$267K	﹤0.01%	1071
2020 Q4	–	Sell	-2,710	Closed	-$133K	–	1880
2020 Q3	$133K	Buy	2,710 +455	+20%	+$25.2K	﹤0.01%	1102
2020 Q2	$131K	Buy	2,255 +1,520	+207%	+$80.3K	﹤0.01%	1099
2020 Q1	$48K	Hold	735	–	–	﹤0.01%	1707
2019 Q4	$48K	Buy	735 +210	+40%	+$12.8K	﹤0.01%	1707
2019 Q3	$30	Buy	525 +40	+8%	+$2.48K	﹤0.01%	1868
2019 Q2	$27	Buy	485 +60	+14%	+$2.78K	﹤0.01%	1938
2019 Q1	$16	Hold	425	–	–	﹤0.01%	2177
2018 Q4	$16	Buy	+425	New	+$16.3K	﹤0.01%	2090
2018 Q3	–	Sell	-425	Closed	-$16K	–	1690
2018 Q2	$16K	Hold	425	–	–	﹤0.01%	1770
2018 Q1	$15K	Hold	425	–	–	﹤0.01%	2059
2017 Q4	$15K	Sell	425 -60	-12%	-$2.13K	﹤0.01%	2059
2017 Q3	$18K	Sell	485 -90	-16%	-$2.83K	﹤0.01%	2009
2017 Q2	$11K	Hold	575	–	–	﹤0.01%	2096
2017 Q1	$11K	Hold	575	–	–	﹤0.01%	2096
2016 Q4	$10K	Hold	575	–	–	﹤0.01%	2111
2016 Q3	$9K	Hold	575	–	–	﹤0.01%	2165
2016 Q2	$7K	Sell	575 -725	-56%	-$10.2K	﹤0.01%	2178
2016 Q1	$20K	Hold	1,300	–	–	﹤0.01%	1822
2015 Q4	$20K	Hold	1,300	–	–	﹤0.01%	1870
2015 Q3	$15K	Hold	1,300	–	–	﹤0.01%	1985
2015 Q2	$18K	Hold	1,300	–	–	﹤0.01%	1940
2015 Q1	$18K	Hold	1,300	–	–	﹤0.01%	1974
2014 Q4	$18K	Hold	1,300	–	–	﹤0.01%	2047
2014 Q3	$16K	Sell	1,300 -300	-19%	-$4.13K	﹤0.01%	2002
2014 Q2	$22K	Hold	1,600	–	–	﹤0.01%	1850
2014 Q1	$26K	Hold	1,600	–	–	﹤0.01%	1827
2013 Q4	$30K	Sell	1,600 -425	-21%	-$7.46K	﹤0.01%	1744
2013 Q3	$38K	Hold	2,025	–	–	﹤0.01%	1650
2013 Q2	$36K	Buy	+2,025	New	+$32.3K	﹤0.01%	1590

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Glenmede Trust's NRC Position: Q2 2024 in Review

Glenmede Trust sold out of NRC Health Common Stock (NRC) in Q2 2024, closing a stake of 7,175 shares — an estimated $284K sold.

Glenmede Trust first reported a position in NRC in Q2 2013 and held it in 41 quarters. The position peaked at $284K in Q1 2024. 136 funds tracked by Wall St. Rank hold NRC as of Q2 2024.

Glenmede Trust reported no remaining NRC Health Common Stock position as of Q2 2024 after selling out during the quarter.
Glenmede Trust sold 7,175 NRC Health Common Stock shares in Q2 2024, an estimated $284K.
Glenmede Trust first reported a position in NRC Health Common Stock in Q2 2013 and held it in 41 quarters.
Glenmede Trust's NRC Health Common Stock position peaked at $284K in Q1 2024.
136 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2024.

Based on Glenmede Trust's 13F filing for Q2 2024, filed 14 Aug 2024.